New Delhi, June 30: Redcliffe Labs today announced the appointment of Kshitiz Singh as Chief Business Officer – Inorganic Growth, as the company strengthens its leadership team to drive the next phase of strategic expansion through acquisitions, partnerships and network integration. The appointment reflects Redcliffe Labs‘ continued focus on building an integrated diagnostics ecosystem that combines pathology, radiology, technology, and preventive healthcare while expanding its presence across regional markets.
As Chief Business Officer – Inorganic Growth, Kshitiz Singh will lead the company’s mergers and acquisitions strategy, strategic partnerships, and post-acquisition integration initiatives. Working closely with the leadership team, he will focus on identifying high-impact growth opportunities, integrating regional diagnostic businesses into Redcliffe Labs‘ operating platform, and strengthening the company’s diagnostics network across India.
Kshitiz joins Redcliffe Labs with more than 26 years of leadership experience across diagnostics, healthcare, pharmaceuticals, FMCG, sales leadership, business development and commercial strategy. Throughout his career, he has led large-scale business operations, expanded regional markets, built high-performing commercial teams, and delivered sustainable business growth across multiple organizations.
Before joining Redcliffe Labs, Kshitiz served as General Manager and Business Head at Agilus Diagnostics, where he played a key role in driving business expansion and strengthening the company’s market presence. Earlier, he held leadership positions at other national-level healthcare companies, Piramal Enterprises, Abbott India, Heinz India, Sanofi, AstraZeneca, and GlaxoSmithKline, gaining extensive experience in diagnostics, commercial strategy, business development, channel management, and organizational growth.
Commenting on the appointment, Aditya Kandoi, Founder & CEO, Redcliffe Labs, said: “The diagnostics industry is entering a phase where scale, integration, and regional reach will define long-term leadership. Across the country, several strong regional diagnostic businesses have built deep clinical expertise and patient trust. We see a significant opportunity to bring these strengths together through an integrated platform that combines technology, clinical excellence, and preventive healthcare. Kshitiz‘s experience across diagnostics and healthcare will help us accelerate this journey while strengthening our presence across regional markets.”
On joining Redcliffe Labs, Kshitiz Singh, Chief Business Officer – Inorganic Growth, said: “India’s diagnostics sector presents a significant opportunity to strengthen healthcare through strategic partnerships and capability building. Redcliffe Labs has built a strong foundation for preventive care driven by its commitment and a clear purpose of adding healthy years to lives. I look forward to working with the leadership to identify the growth opportunities, forge strong partnerships, and strengthen our network to bring trusted, high-quality diagnostics to more people across the country.”
The appointment further strengthens Redcliffe Labs‘ leadership team as the company continues to expand its integrated diagnostics network and build long-term capabilities through strategic partnerships, acquisitions, and technology-led growth.